147 related articles for article (PubMed ID: 35093442)
1. Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis.
Zhang Q; Li D; Guan S; Liu D; Wang J; Xing G; Yue L; Cai D
Int J Biol Macromol; 2022 Apr; 203():280-291. PubMed ID: 35093442
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
[TBL] [Abstract][Full Text] [Related]
3. Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis.
Li X; Guan S; Li H; Li D; Liu D; Wang J; Zhu W; Xing G; Yue L; Cai D; Zhang Q
Drug Deliv; 2023 Dec; 30(1):2181746. PubMed ID: 36803115
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
[TBL] [Abstract][Full Text] [Related]
6. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
7. Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles.
Zou Y; Zhou Y; Jin Y; He C; Deng Y; Han S; Zhou C; Li X; Zhou Y; Liu Y
ACS Appl Mater Interfaces; 2018 Jun; 10(22):18585-18600. PubMed ID: 29749228
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
[TBL] [Abstract][Full Text] [Related]
9. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
10. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Wang WD; Shang Y; Li Y; Chen SZ
Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
[TBL] [Abstract][Full Text] [Related]
11. Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Sun J; Li J; Liu Q; Jiang M; Yang M; Zhan S; Qiu T; He K; Zhang X
Eur J Pharm Sci; 2020 Apr; 146():105277. PubMed ID: 32105783
[TBL] [Abstract][Full Text] [Related]
12. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
13. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma.
Zhang X; Chen H; Zhang Y; Huang Q; Feng J; Xing H; Fu X; Yan X; Zhang Y; Xu Q; Liang J
Int J Nanomedicine; 2022; 17():5137-5151. PubMed ID: 36345507
[TBL] [Abstract][Full Text] [Related]
14. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y
Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183
[No Abstract] [Full Text] [Related]
15. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs.
Jung B; Shim MK; Park MJ; Jang EH; Yoon HY; Kim K; Kim JH
Int J Pharm; 2017 Mar; 520(1-2):111-118. PubMed ID: 28179099
[TBL] [Abstract][Full Text] [Related]
17. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer.
Sabra SA; Elzoghby AO; Sheweita SA; Haroun M; Helmy MW; Eldemellawy MA; Xia Y; Goodale D; Allan AL; Rohani S
Eur J Pharm Biopharm; 2018 Jul; 128():156-169. PubMed ID: 29689288
[TBL] [Abstract][Full Text] [Related]
20. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]